Induction of paranodal myelin detachment and sodium channel loss in vivo by Campylobacter jejuni DNA-binding protein from starved cells (C-Dps) in myelinated nerve fibers

Journal of the Neurological Sciences

Volumn 288, Issue 1-2, 2010, Pages 54-62

  Piao, Hua ^a   Minohara, Motozumi ^a   Kawamura, Nobutoshi ^a   Li, Wei ^a   Mizunoe, Yoshimitsu ^a   Umehara, Fujio ^b   Goto, Yoshinobu ^a   Kusunoki, Susumu ^c   Matsushita, Takuya ^a   Ikenaka, Kazuhiro ^d   Maejima, Takashi ^d   Nabekura, Jun ichi ^d   Yamasaki, Ryo ^a   Kira, Jun ichi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NATIONAL INSTITUTE FOR PHYSIOLOGICAL SCIENCES   (Japan)

Author keywords

Axonal degeneration; Campylobacter jejuni; DNA binding protein from starved cells; Guillain Barr syndrome; Paranodal demyelination

Indexed keywords

ANTIBODY; BACTERIAL PROTEIN; DNA BINDING PROTEIN; GLYCOLIPID; NEUTROPHIL ACTIVATING PROTEIN; SODIUM CHANNEL; SODIUM ION; SULFATIDE; SULFATIDE ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAMPYLOBACTER ENTERITIS; CAMPYLOBACTER JEJUNI; CAUDA EQUINA; CONTROLLED STUDY; ELECTRON MICROSCOPY; ELECTROPHYSIOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GUILLAIN BARRE SYNDROME; HELICOBACTER PYLORI; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MACROPHAGE; MUSCLE ACTION POTENTIAL; MYELIN SHEATH; MYELINATED NERVE; NERVE FIBER; NERVE FIBER DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RAT; SCIATIC NERVE; THIN LAYER CHROMATOGRAPHY;

ANIMALS; ANTIBODIES, MONOCLONAL; AXONS; CAMPYLOBACTER JEJUNI; CHROMATOGRAPHY, THIN LAYER; DNA-BINDING PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GANGLIOSIDES; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON; MYELIN SHEATH; NERVE DEGENERATION; NERVE FIBERS, MYELINATED; NEURAL CONDUCTION; PATCH-CLAMP TECHNIQUES; PERIPHERAL NERVES; RATS; RATS, INBRED LEW; RECOMBINANT PROTEINS; SCIATIC NERVE; SODIUM CHANNELS;

EID: 71049139746     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2009.10.007     Document Type: Article

References (40)

1. Yuki N. Infectious origins of, and molecular mimicry in, Guillain-Barré and Fisher syndromes. Lancet Infect Dis 1 (2001) 29-37
2. Griffin J.W., Li C.Y., Macko C., Ho T.W., Hsieh S.T., Xue P., et al. Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barré syndrome. J Neurocytol 25 (1996) 33-51
3. Ariga T., and Yu R.K. Antiglycolipid antibodies in Guillain-Barré syndrome and related diseases: review of clinical features and antibody specificities. J Neurosci Res 80 (2005) 1-17
4. Willison H.J., and Yuki N. Peripheral neuropathies and anti-glycolipid antibodies. Brain 125 (2002) 2591-2625
5. Hirota N., Kaji R., Bostock H., Shindo K., Kawasaki T., Mizutani K., et al. The physiological effect of anti-GM1 antibodies on saltatory conduction and transmembrane currents in single motor axons. Brain 120 (1997) 2159-2169
6. Sheikh K.A., Zhang G., Gong Y., Schnaar R.L., and Griffin J.W. An anti-ganglioside antibody-secreting hybridoma induces neuropathy in mice. Ann Neurol 56 (2004) 228-239
7. Ishikawa T., Mizunoe Y., Kawabata S., Takade A., Harada M., Wai S.H., et al. The iron-binding protein Dps confers hydrogen peroxide stress resistance to Campylobacter jejuni. J Bacteriol 185 (2003) 1010-1017
8. Teneberg S., Miller-Podraza H., Lampert H.C., Evans Jr. D.J., Evans D.G., Danielsson D., et al. Carbohydrate binding specificity of the neutrophil-activating protein of Helicobacter pylori. J Biol Chem. 272 (1997) 19067-19071
9. Honke K., Hirahara Y., Dupree J., Suzuki K., Popko B., Fukushima K., et al. Paranodal junction formation and spermatogenesis require sulfoglycolipids. Proc Natl Acad Sci USA 99 (2002) 4227-4232
10. Ishibashi T., Dupree J.L., Ikenaka K., Hirahara Y., Honke K., Peles E., et al. A myelin galactolipid, sulfatide, is essential for maintenance of ion channels on myelinated axon but not essential for initial cluster formation. J Neurosci 22 (2002) 6507-6514
11. Carpo M., Meucchi N., Allaria S., Marmiroli P., Monaco S., Toscano A., et al. Anti-sulfatide IgM antibodies in peripheral neuropathy. J Neurol Sci 176 (2000) 144-150
12. Erb S., Ferracin F., Fuhr P., Rosler K.M., Hess C.W., Kuntzer T., et al. Polyneuropathy attributes: a comparison between patients with anti-MAG and anti-sulfatide antibodies. J Neurol 247 (2000) 767-772
13. Nardelli E., Bassi A., Mazzi G., Anzini P., and Rizzuto N. Systemic passive transfer studies using IgM monoclonal antibodies to sulfatide. J Neuroimmunol 63 (1995) 29-37
14. Uncini A., Di Muzio A., Di Guglielmo G., De Angelis M.V., De Luca G., Lugaresi A., et al. Effect of rhTNF-alpha injection into rat sciatic nerve. J Neuroimmunol 94 (1999) 88-94
15. Mizoguchi Y., Ishibashi H., and Nabekura J. The action of BDNF on GABAA currents changes from potentiating to suppressing during maturation of rat hippocampal CA1 pyramidal neurons. J Physiol 548 (2003) 703-709
16. Yuki N., and Kuwabara S. Axonal Guillain-Barre syndrome: carbohydrate mimicry and pathophysiology. J Perihperal Nerv Sys 12 (2007) 238-249
17. Li C.Y., Xue P., Tian W.Q., Liu R.C., and Yang C. Experimental Campylobacter jejuni infection in the chicken: an animal model of axonal Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 61 (1996) 279-284
18. Yuki N., Yamada M., Koga M., Odaka M., Susuki K., Tagawa Y., et al. Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside. Ann Neurol 49 (2001) 712-720
19. Susuki K., Nishimoto Y., Yamada M., Baba M., Ueda S., Hirata K., et al. Acute motor axonal neuropathy rabbit model: immune attack on nerve root axons. Ann Neurol 54 (2003) 383-388
20. Kuwabara S., Ogawara K., Sung J.Y., Mori M., Kanai K., Hattori T., et al. Differences in membrane properties of axonal and demyelinating Guillain-Barré syndromes. Ann Neurol 52 (2002) 180-187
21. Kuwabara S., Ogawara K., Misawa S., Koga M., Mori M., Hiraga A., et al. Does Campylobacter jejuni infection elicit "demyelinating" Guillain-Barré syndrome?. Neurology 63 (2004) 529-533
22. Ho T.W., Mishu B., Li C.Y., Gao C.Y., Cornblath D.R., Griffin J.W., et al. Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 118 (1995) 597-605
23. McKhann G.M., Cornblath D.R., Griffin J.W., Ho T.W., Li C.Y., Jiang Z., et al. Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol 33 (1993) 333-342
24. Griffin J.W., Li C.Y., Ho T.W., Xue P., Macko C., Gao C.Y., et al. Guillain-Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases. Brain 118 (1995) 577-595
25. Li S., Liquari P., McKee K.K., Harrison D., Patel R., Lee S., et al. Laminin-sulfatide binding initiates basement membrane assembly and enables receptor signaling in Schwann cells and fibroblasts. J Cell Biol 169 (2005) 179-189
26. Saito F., Moore S.A., Barresi R., Henry M.D., Messing A., Ross-Barta S.E., et al. Unique role of dystroglycan in peripheral nerve myelination, nodal structure, and sodium channel stabilization. Neuron 38 (2003) 747-758
27. Lopate G., Parks B.J., Goldstein J.M., Yee W.C., Friesenhahn G.M., and Pestronk A. Polyneuropathies associated with high titre antisulfatide antibodies: characteristics of patients with and without serum monoclonal proteins. J Neurol Neurosurg Psychiatry 62 (1997) 581-585
28. Dabby R., Weimer L.H., Hays A.P., Olarte M., and Latov N. Antisulfatide antibodies in neuropathy: clinical and electrophysiologic correlates. Neurology 54 (2000) 1448-1452
29. 1b ganglioside antibodies in Guillain-Barré syndrome. J Infect Dis 176 (1997) S144-S149
30. + currents in isolated rat myelinated nerve fibers. Ann Neurol 37 (1995) 436-442
31. Buchwald B., Toyka K.V., Zielasek J., Weishaupt A., Schweiger S., and Dudel J. Neuromuscular blockade by IgG antibodies from patients with Guillain-Barré syndrome: a macro-patch-clamp study. Ann Neurol 44 (1998) 913-922
32. Dilley A., Gregson N.A., Hadden R.D.M., and Smith K.J. Effects on axonal conduction of anti-ganglioside sera and sera from patients with Guillain-Barré syndrome. J Neuroimmunol 139 (2003) 133-140
33. Susuki K., Rasband M.N., Tohyama K., Koibuchi K., Okamoto S., Funakoshi K., et al. Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers. J Neurosci 27 (2007) 3956-3967
34. Press R., Mata S., Lolli F., Zhu J., Andersson T., and Link H. Temporal profile of anti-ganglioside antibodies and their relation to clinical parameters and treatment in Guillain-Barré syndrome. J Neurol Sci 190 (2001) 41-47
35. van Spreeuwel J.P., Duursma G.C., Meijer C.J., Bax R., Rosekrans P.C., and Lindeman J. Campylobacter colitis: histological immunohistochemical and ultrastructural findings. Gut 26 (1985) 945-951
36. Hu L., Bray M.D., Osorio M., and Kopecko D.J. Campylobacter jejuni induces maturation and cytokine production in human dendritic cells. Infect Immun 74 (2006) 2697-2705
37. Jones M.A., Tötemeyer S., Maskel D.J., Bryant C.E., and Barrow P.A. Induction of proinflammatory responses in the human monocytic cell line THP-1 by Campylobacter jejuni. Infect Immun 71 (2003) 2626-2633
38. Sharief M.K., McLean B., and Thompson E.J. Elevated serum levels of tumor necrosis factor-alpha in Guillain-Barré syndrome. Ann Neurol 33 (1993) 591-596
39. Xaio H., Banks W.A., Niehoff M.L., and Morley J.E. Effect of LPS on the permeability of the blood-brain barrier to insulin. Brain Res 896 (2001) 36-42
40. Usuki S., Nakatani Y., Taguchi K., Fujita T., Tanabe S., Ustunomiya I., et al. Topology and patch-clamp analysis of the sodium channel in relationship to the anti-lipid A antibody in Campylobacteriosis. J Neurosci Res 86 (2008) 3359-3374